RSS   Newsletter   Contact   Advertise with us
Post Online Media

Phio Pharmaceuticals appoints Gerrit Dispersyn as CEO

Share on Twitter Share on LinkedIn
Staff Writer | Marlborough, Mass., USA | Monday February 18, 2019 4:51AM ET
Gerrit DispersynPhio Pharmaceuticals, a biotechnology company, appointed Gerrit Dispersyn, currently president and COO, as the company's new CEO, effective March 1, 2019.
Please disable your ad blocker for POST to be able to enjoy our free content.


Dr. Cauwenbergh was elected President and CEO of Phio Pharmaceuticals when the business was spun-off from its parent company, then known as Galena Biopharma in April 2012.

Dr. Cauwenbergh was also elected to serve as a member of the Board of Directors.

Prior to his current role, he was elected Chief Development Officer of the Company in April 2017.

Over the past two years, Dr. Dispersyn has provided exemplary leadership to the research and development team at Phio Pharmaceuticals.

 

 LATEST MOVES FROM Massachusetts 


POST Online Media Contact

 More inside POST